Kehl, Germany

Ruth Greferath

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Ruth Greferath: Innovator in Immunology and Cellular Biology

Introduction

Ruth Greferath is a distinguished inventor based in Kehl, Germany, known for her significant contributions to the fields of immunology and cellular biology. With a total of 12 patents to her name, she has developed innovative solutions that address critical health challenges.

Latest Patents

One of her latest patents is titled "Antibodies obtainable using supramolecular constructs." This invention comprises novel compositions and methods for eliciting high immune responses, yielding conformationally sensitive antibodies that recognize specific epitopes on various antigens, including amyloid protein and prion protein. The unique modification methodology of this invention is applicable to a variety of peptides and can ultimately be employed in therapeutic formulations and vaccines for diseases such as Alzheimer's disease. Another notable patent is "Inositol pyrophosphates, and methods of use thereof." This invention includes compounds and methods capable of delivering modified inositol hexaphosphate to the cytoplasm of mammalian cells, enhancing the ability of red blood cells to deliver oxygen.

Career Highlights

Ruth has worked with several prominent companies, including Normoxys, Inc. and Ac Immune SA. Her work has significantly advanced the understanding and treatment of various diseases through innovative research and development.

Collaborations

Ruth has collaborated with notable scientists such as Yves Claude Nicolau and Jean-Marie Lehn, further enhancing her contributions to the scientific community.

Conclusion

Ruth Greferath's innovative work in immunology and cellular biology has led to significant advancements in medical science. Her patents reflect her commitment to developing solutions that can improve health outcomes for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…